Ameet Patel, MD, MMHC
Medical Oncology, Hematology, Blood and Marrow Transplantation
Patient Reviews Request Appointment
Dr. Patel believes in OHC’s mission and recognizes the importance of placing patients first for accessibility of cutting-edge treatment. “My personal mission is to provide the same level of compassion and expert level care for my patients as if they were my own family. Having volunteered to drive my neighbor several times for expert leukemia care, I know the personal challenges.” Dr. Patel also believes that cancer care is personalized and requires a team effort to meet the needs of his patients and caregivers.
Dr. Patel has a special interest in CAR T-cell therapy and bone marrow transplant. He is published in numerous international peer-reviewed journals and has presented at numerous national meetings, including the American Society of Transplant and Cellular Therapy (ASTCT) and American Society of Hematology.
He has a master’s degree in healthcare administration with a focus on improving access and alleviating financial toxicity for CAR-T for practices and patients. He has personally worked as a chief clinical fellow to improve financial decision analysis and improve healthcare delivery for patients receiving CAR T-cell therapy at the beloved institution he trained.
Education & Training
Medical School: University of Florida College of Medicine
Residency, Internal Medicine: University of Maryland Medical Center
Fellowship, Hematology/Oncology: Vanderbilt University Medical Center
Additional Education: Vanderbilt University Owen’s School of Business, Master of Management in Health Care
Board Certified in Internal Medicine
American Board of Internal Medicine, Oncology
American Board of Internal Medicine, Hematology
Dr. Patel brings a keen sense of empathy and compassion to each one of his patients and brings a wealth of knowledge about advances in CAR T-cell therapy to our team. He’s respected in our field and is driven by making cutting-edge therapies accessible to all patients. - Dr. Essell, OHC medical oncologist and hematologist, October 2022